Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India flag India · Delayed Price · Currency is INR
14.00
-0.55 (-3.78%)
Jun 1, 2026, 12:56 PM IST

NSE:NIDAN Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
255.42245.28241.77242.66296.6
Other Revenue
18.56----
273.97245.28241.77242.66296.6
Revenue Growth (YoY)
11.70%1.45%-0.36%-18.19%42.65%
Cost of Revenue
1019.5321.9324.6737.7
Gross Profit
263.97225.74219.84217.99258.9
Selling, General & Admin
43.0247.6348.6251.5838.54
Other Operating Expenses
153.97125.81106.7898.37126.22
Operating Expenses
215.97197.53184.06180.94191.07
Operating Income
4828.2235.7837.0567.83
Interest Expense
-19.56-20.66-20.86-20.95-24.35
Interest & Investment Income
-20.4626.4628.840.05
Other Non Operating Income (Expenses)
--0.730.050.48-1.22
EBT Excluding Unusual Items
28.4427.2941.4445.4342.31
Gain (Loss) on Sale of Assets
-0.32-2.692.89
Other Unusual Items
-4--65.13--
Pretax Income
24.4427.6-23.6948.1245.2
Income Tax Expense
9.387.838.6412.7218.58
Net Income
15.0619.77-32.3235.426.63
Net Income to Common
15.0619.77-32.3235.426.63
Net Income Growth
-23.82%--32.92%15.66%
Shares Outstanding (Basic)
1414141411
Shares Outstanding (Diluted)
1414141411
Shares Change (YoY)
0.32%--21.22%15.83%
EPS (Basic)
1.081.42-2.332.552.32
EPS (Diluted)
1.081.42-2.332.552.32
EPS Growth
-23.94%--9.76%-0.24%
Free Cash Flow
11.913.3647.84103.017.53
Free Cash Flow Per Share
0.850.963.447.410.66
Gross Margin
96.35%92.04%90.93%89.83%87.29%
Operating Margin
17.52%11.50%14.80%15.27%22.87%
Profit Margin
5.50%8.06%-13.37%14.59%8.98%
Free Cash Flow Margin
4.35%5.45%19.79%42.45%2.54%
EBITDA
66.9852.2664.3567.994.06
EBITDA Margin
24.45%21.31%26.61%27.98%31.71%
D&A For EBITDA
18.9824.0528.5730.8426.23
EBIT
4828.2235.7837.0567.83
EBIT Margin
17.52%11.50%14.80%15.27%22.87%
Effective Tax Rate
38.38%28.38%-26.44%41.09%
Revenue as Reported
273.97267.78269.24275.95300.62